The long-term functional consequences of acute infectious diarrhea

Current Opinion in Gastroenterology

Volumn 32, Issue 1, 2016, Pages

  Cocciolillo, Sila ^a   Collins, Stephen M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Dysbiosis; dysfunction; infection; microbiota; postinfectious irritable bowel syndrome

Indexed keywords

CANNABINOID; HOST FACTOR;

ACUTE INFECTIOUS DIARRHEA; CYTOKINE RESPONSE; DYSBIOSIS; GASTROINTESTINAL TRACT FUNCTION; GENE LOCUS; GENETIC PREDISPOSITION; HEREDITY; HOST; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFECTIOUS DIARRHEA; INTESTINE FLORA; INTESTINE MOTILITY; NONHUMAN; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW; RISK FACTOR; VISCERAL PAIN; COMPLICATION; DIARRHEA; GASTROENTERITIS; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; IMMUNOLOGY; IRRITABLE BOWEL SYNDROME; MICROBIOLOGY; MUCOSAL IMMUNITY; PROGNOSIS;

DIARRHEA; DYSBIOSIS; GASTROENTERITIS; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, MUCOSAL; IRRITABLE BOWEL SYNDROME; PROGNOSIS; RISK FACTORS;

EID: 84951568725     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0000000000000233     Document Type: Review

References (33)

1. Futagami S, Itoh T, Sakamoto C. Systemic review with meta-analysis: postinfectious functional dyspepsia. Alimentary Pharmacol Ther 2015; 41:177-188.
2. Pike BL, Porter CK, Sorrell TJ, Riddle MS. Acute gastroenteritis and the risk of functional dyspepsia: a systematic review and meta-analysis. Am J Gastroenterol 2013; 108:1558-1563.
3. Schwille-Kiuntke J, Mazurak N, Enck P. Systematic review with meta-analysis: postinfectious irritable bowel syndrome after travellers' diarrhoea. Aliment Pharmacol Ther 2015; 41:1029-1037.
4. Grover M, Camilleri M, Smith K, et al. On the fiftieth anniversary postinfectious irritable bowel syndrome: mechanisms related to pathogens. Neurogastroenterol Motil 2014; 26:156-167.
5. Grover M. Role of gut pathogens in development of irritable bowel syndrome. Indian J Med Res 2014; 139:11-18.
6. Beatty JK, Bhargava A, Buret AG. Postinfectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection. World J Gastroenterol 2014; 20:3976-3985.
7. Bennet SMP,Öhman L, Simrén M. Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver 2015; 9:318-331.
8. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in postdysenteric irritable bowel syndrome. Gut 2000; 47:804-811.
9. Yarandi SS, Christie J. Functional dyspepsia in review: pathophysiology and challenges in the diagnosis and management due to coexisting gastroesophageal reflux disease and irritable bowel syndrome. Gastroenterol Res Prac 2013; 351086.
10. Collins SM. A role of gut microbiota in IBS. Nat Rev Gastroenterol Hepatol 2014; 11:497-505.
11. Collins SM, Chang C, Mearin F. Postinfectious chronic gut dysfunction: from bench to bedside. Am J Gastroenterol Suppl 2012; 1:2-8.
12. Verdu EF, Riddle MS. Chronic gastrointestinal consequences of acute infectious diarrhea: evolving concepts in epidemiology and pathogenesis. Am J Gastroenterol 2012; 107:981-989.
13. Villani AC, Lemire M, Thabane M, et al. Genetic risk factors for postinfectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology 2010; 138:1502-1513.
14. Saito YA, Larson JJ, Atkinson EJ, et al. The role of 5-HTT LPR and GNbeta3 825C>T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS). Dig Dis Sci 2012; 57:2650-2657.
15. Wouters M, Van Wanrooy S, Nguyen A, et al. Psychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritis. Gut 2015; 0:1-10.
16. Marshall JK, Thabane M, Garg AX, et al. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment Pharmacol Ther 2004; 20:1317-1322.
17. Vanheel H, Vicario M, Vanuytsel T, et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut 2014; 63:262-271.
18. Shunji I, Yasumasa T, Nobuhiko F, et al. Pathogenesis of irritable bowel syndrome-review regarding associated infection and immune activation. Digestion 2013; 87:2014-2211.
19. Darkoh C, Comer L, Zewsie G, et al. Chemotactic chemokines are important in the pathogenesis of irritable bowel syndrome. PLoS One 2014; 3:e93144.
20. Chen J, Zhang Y, Deng Z. Imbalanced shift of cytokine expression between T helper 1 and T helper 2 (Th1/Th2) in intestinal mucosa of patients with postinfectious irritable bowel syndrome. BMC Gastroenterol 2012; 12:91.
21. Sundin J, Rangel I, Kumawat AK, et al. Aberrant mucosal lymphocyte number and subsets in the colon of postinfectious IBS patients. Scand J Gastroenterol 2014; 49:1068-1075.
22. Pike BL, Paden AP, Alcala AN, et al. Immunological biomarkers in postinfectious irritable bowel syndrome. J Travel Med 2015; 22:242-250.
23. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad USA 2011; 108:4554-4561.
24. Knoop KA, McDonald K, Kulkarni DH, Newberry RD. Antibiotics promote inflammation through the translocation of native commensal colonic bacteria. Gut 2015. [Epub ahead of print]
25. Sundin J, Rangel I, Fuentes S, et al. Altered faecal and mucosal microbial composition in postinfectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress. Aliment Pharmacol Ther 2015; 41:342-351.
26. Jalanka-Touvinene J, Salojä rvi A, Salonen A, et al. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut 2014; 63:1737-1745.
27. Sundin J, Rangel I, Repsilber D, Brummer RJ. Cytokine response after stimulation with key commensal bacteria differ in post-infectious irritable bowel syndrome (PI-IBS) patients compared to healthy controls. PLoS One 2015; 14:e0134836.
28. De Palma G, Collins SM, Bercik P. The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes 2014; 3:419-429.
29. Wang H, Gong J, Wang W, et al. Are there any different effects of bifidobacterium, lactobacillus and streptococcus on intestinal sensation, barrier function and intestinal immunity in PI-IBS mouse model PLoS One 2014; 9:e90153.
30. Sarna SK. Lessons learnt from postinfectious IBS. Front Physiol 2011; 2:49.
31. Song J, Zhang L, Bai T, et al. Mast cell-dependent mesenteric afferent activation by mucosal supernatant from different bowel segments of guinea pigs with postinfectious irritable bowel syndrome. J Neurogastroenterol Motil 2015; 21:236-246.
32. Feng CC, Yan XJ, Chen X, et al. Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats. Pain 2014; 155:1591-1604.
33. Jard F, Fernà ndez-Blanco JA, Martnez V, Vergara P. Plasticity of dorsal root ganglion neurons in a rat model of postinfectious gut dysfunction: potential implication of nerve growth factor. Scand J Gastroenterol 2014; 49:1296-1303.